The Rest of those “Extra Paychecks” from Leeb’s “MCR Plan”

By Travis Johnson, Stock Gumshoe, November 5, 2012

As promised, we’re following up with the rest of the picks that Stephen Leeb (sorry, Dr. Stephen Leeb) is pitching as his “MCR” Plan.

If you missed our first entry as we began demystifying this particular ad, you can see it here — the short version is, he’s touting dividend paying stocks in the medical business, mostly pharmaceutical companies. The “MCR,” which they, of course, made up to be a mysterious-sounding term, stands for Medical Capital Returns, and there’s a lot of hoop-de-doo about it, but basically it’s just about cashing your dividend checks.

The first one he teased was Eli Lilly (LLY), the second one was Merck (MRK), so let’s see who else he has for us.

“MCR Component # 3

“Put Your Dollars At the Forefront of Cancer Research

“MCR3 allows you to be rewarded for the fight against America‚Äôs most dreaded diseas